These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11460513)

  • 1. Development of pulmonary fibrosis in fibrinogen-deficient mice.
    Wilberding JA; Ploplis VA; McLennan L; Liang Z; Cornelissen I; Feldman M; Deford ME; Rosen ED; Castellino FJ
    Ann N Y Acad Sci; 2001; 936():542-8. PubMed ID: 11460513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.
    Ploplis VA; Wilberding J; McLennan L; Liang Z; Cornelissen I; DeFord ME; Rosen ED; Castellino FJ
    Am J Pathol; 2000 Sep; 157(3):703-8. PubMed ID: 10980108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
    Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF
    J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.
    Eitzman DT; McCoy RD; Zheng X; Fay WP; Shen T; Ginsburg D; Simon RH
    J Clin Invest; 1996 Jan; 97(1):232-7. PubMed ID: 8550840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
    Sisson TH; Hattori N; Xu Y; Simon RH
    Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerization of fibrinogen in murine bleomycin-induced lung injury.
    Olman MA; Simmons WL; Pollman DJ; Loftis AY; Bini A; Miller EJ; Fuller GM; Rivera KE
    Am J Physiol; 1996 Oct; 271(4 Pt 1):L519-26. PubMed ID: 8897898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice.
    Madtes DK; Elston AL; Hackman RC; Dunn AR; Clark JG
    Am J Respir Cell Mol Biol; 1999 May; 20(5):924-34. PubMed ID: 10226062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
    Günther A; Lübke N; Ermert M; Schermuly RT; Weissmann N; Breithecker A; Markart P; Ruppert C; Quanz K; Ermert L; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1358-65. PubMed ID: 14644925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAI-1, fibrosis, and the elusive provisional fibrin matrix.
    Loskutoff DJ; Quigley JP
    J Clin Invest; 2000 Dec; 106(12):1441-3. PubMed ID: 11120750
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice.
    Li Y; Azuma A; Takahashi S; Usuki J; Matsuda K; Aoyama A; Kudoh S
    Chest; 2002 Dec; 122(6):2137-45. PubMed ID: 12475858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?
    Pottier N; Chupin C; Defamie V; Cardinaud B; Sutherland R; Rios G; Gauthier F; Wolters PJ; Berthiaume Y; Barbry P; Mari B
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1098-107. PubMed ID: 17673693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways.
    Blaauboer ME; Emson CL; Verschuren L; van Erk M; Turner SM; Everts V; Hanemaaijer R; Stoop R
    Matrix Biol; 2013; 32(7-8):424-31. PubMed ID: 23648810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin.
    Lawson WE; Polosukhin VV; Stathopoulos GT; Zoia O; Han W; Lane KB; Li B; Donnelly EF; Holburn GE; Lewis KG; Collins RD; Hull WM; Glasser SW; Whitsett JA; Blackwell TS
    Am J Pathol; 2005 Nov; 167(5):1267-77. PubMed ID: 16251411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor NRF2 protects against pulmonary fibrosis.
    Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
    FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.
    Nakanishi T; Hasegawa Y; Mimura R; Wakayama T; Uetoko Y; Komori H; Akanuma S; Hosoya K; Tamai I
    PLoS One; 2015; 10(4):e0123895. PubMed ID: 25923111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
    Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
    Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
    Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
    J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.